ParaZero completes successful blood delivery trial with Israeli agencies

Published 09/09/2025, 13:22
ParaZero completes successful blood delivery trial with Israeli agencies

KFAR SABA, Israel - ParaZero Technologies Ltd. (Nasdaq:PRZO), a $22.87 million market cap drone technology company, has successfully completed a joint field trial of its DropAir system for precision delivery of blood units, the company announced Tuesday.

The trial, conducted in collaboration with the Israeli Ministry of Defense Directorate of Defense R&D (MAFAT), the Israeli Ministry of Health, and the Israel Defense Forces (IDF), demonstrated the system’s ability to safely deliver blood transfusions from an altitude of 200 meters above ground level.

Following the aerial drop, doctors at the Rambam Medical Center inspected the blood units and confirmed they remained undamaged and fully suitable for human transfusion, according to the company’s statement.

"When forces in the field urgently require fresh blood transfusions but cannot be reached by conventional means, we believe that DropAir could provide a precise, safe, and reliable delivery solution," said Ariel Alon, CEO of ParaZero.

The DropAir system is designed for autonomous aerial delivery of sensitive payloads including medical supplies, tactical equipment, and humanitarian aid. The company states the system features a compact design for both military and civilian applications.

ParaZero, founded in 2014, specializes in drone technologies including autonomous parachute recovery systems and counter-UAS platforms. The company has shown strong revenue growth of 80.42% over the last twelve months, though InvestingPro analysis indicates rapid cash burn and profitability challenges. The company’s announcement was based on a press release statement.[Get detailed insights and 12 additional ProTips for ParaZero with InvestingPro]

In other recent news, ParaZero Technologies Ltd. has completed several successful trials of its drone defense systems. The company announced the completion of a field trial for its DefendAir Stationary Turret system with Israel’s homeland security authority, achieving a 100% interception success rate. Additionally, ParaZero successfully tested its DefendAir Hand-Held Net Gun System for a branch of Israel’s defense sector, also recording a 100% success rate in neutralizing drone threats. The company further announced receiving a purchase order for its Counter-Unmanned Aerial Systems solution from an unnamed defense entity, indicating a step forward in its expansion within the defense market.

In another development, ParaZero completed a field trial of an enhanced variant of its DefendAir anti-drone system, featuring a stationary net turret launcher for 360-degree perimeter defense. The system’s advanced optical detection and tracking capabilities allow for fully autonomous operation. Furthermore, ParaZero received marketing approval from Israel’s Defense Export Controls Agency for its DropAir Precision Airdrop System, integrated with Steadicopter’s unmanned platforms. This approval enables the marketing of their joint solution to global clients in commercial, defense, and humanitarian sectors.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.